Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results

N M Albiger1, G Occhi, B Mariniello

  • 1Department of Medical and Surgical Sciences Endocrinology Unit, University of Padua, via Ospedale 105, 35128 Padua, Italy. nalbiger@yahoo.com

Abstract

Insights

Aberrant G-protein-coupled receptor expression, specifically glucose-dependent insulinotropic polypeptide (GIP) and LH-receptor, was identified in ACTH-independent macronodular adrenal hyperplasia (AIMAH). This finding may enable targeted therapies and supports unilateral adrenalectomy as an initial treatment option.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Surgical Oncology

Background:

  • ACTH-independent macronodular adrenal hyperplasia (AIMAH) is characterized by cortisol hypersecretion, often managed by bilateral adrenalectomy.
  • Aberrant expression of G-protein-coupled receptors on adrenal glands is implicated in AIMAH pathophysiology.
  • Investigating specific receptor profiles can reveal therapeutic targets and inform treatment strategies for AIMAH.

Observation:

  • A patient with AIMAH exhibited cortisol and androgen excess, with bilateral adrenal macronodules.
  • In vivo stimulation tests revealed abnormal cortisol responses to meals and glucose.
  • In vitro studies on adrenal tissue demonstrated overexpression of glucose-dependent insulinotropic polypeptide (GIP) and LH receptors.

Findings:

  • Octreotide therapy partially blunted cortisol response and improved urinary free cortisol (UFC) levels.
  • Unilateral adrenalectomy confirmed AIMAH and revealed coexisting GIP and LH-receptor overexpression in adrenal nodules and adjacent cortex.
  • Post-surgery, UFC and androgen levels normalized, leading to clinical improvement.

Implications:

  • Coexistence of GIP and LH-receptor expression in AIMAH influences the disease's phenotype, suggesting potential for targeted pharmacological interventions.
  • Specific receptor profiling may guide personalized medical treatments for AIMAH.
  • Unilateral adrenalectomy presents a viable initial surgical option for asymmetric bilateral adrenal hyperplasia, preserving adrenal function where possible.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...